about
Migraine and coronary heart disease in women and menUse and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.Cardiovascular tolerability and safety of triptans: a review of clinical data.Tolerability of sumatriptan: clinical trials and post-marketing experience.Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.Long-term use of daily sumatriptan injections in severe drug-resistant chronic cluster headachePreventive agents for migraine: focus on the antiepileptic drugs.Triptans and troponin: a case reportSumatriptan therapy for headache and acute myocardial infarction.QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 1: review of serotonergic cardiac adverse events with a triptan case.Intravenous sodium valproate aborts migraine headaches rapidly.Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine.Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients.Spinal cord infarction during use of zolmitriptan: a case report.Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan.Treatment choices and patterns in migraine patients with and without a cardiovascular risk profile.A case of myocardial infarction with sumatriptan use.Thyrotoxicosis, sumatriptan and coronary artery spasm.
P2860
Q28193998-5C7A36A4-A6F0-482E-BBB0-D9488C0A511CQ30584718-35418F5D-1CDA-4370-B152-8EB3F10D8F44Q30932202-98C3AA2B-7484-4EFE-8BF3-E7765ED184C8Q34135363-DC0401C8-70E8-454F-8984-D1F0CFBF5D4DQ34481198-873B8A48-49E9-4B14-B1C6-81291DDC9393Q34647540-5E9325BD-9D28-493F-9010-69B773AA1664Q36516759-AE1E0925-3A7B-4A80-897E-8A3CFBF6B92AQ36748706-E939F0AF-F93E-4E97-8618-40149F6DC4B8Q37251602-24FE80F0-12B2-47AA-90DF-0E1A0B1949F2Q37803238-031D368F-7D3B-49AA-97D7-C75F688031E8Q38065274-9C9E2EC8-7AA2-4A2B-B1B8-6BAD1E40F886Q39284203-C3E33F16-7486-4F31-BF4A-81FD95E2FFBFQ39413834-A27658B8-0C89-4101-9C0A-26A07542FCBEQ41289268-CE44ECFA-B4F0-4769-A149-133CEBFD19E5Q41729628-39C4CB58-5366-4BE5-B37A-68F5F32233FAQ42538062-411E5644-4447-4208-83A3-4C56AD15B478Q46120628-2F9A362B-676E-411E-88B8-914EF8AAAEAAQ46865690-6EE5165E-F55B-4188-A05A-F840A7F6A120Q55462948-B0E0263D-3DCB-42CF-81A3-6DEF0A2189FF
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Cardiac arrest following use of sumatriptan.
@ast
Cardiac arrest following use of sumatriptan.
@en
Cardiac arrest following use of sumatriptan.
@nl
type
label
Cardiac arrest following use of sumatriptan.
@ast
Cardiac arrest following use of sumatriptan.
@en
Cardiac arrest following use of sumatriptan.
@nl
prefLabel
Cardiac arrest following use of sumatriptan.
@ast
Cardiac arrest following use of sumatriptan.
@en
Cardiac arrest following use of sumatriptan.
@nl
P356
P1433
P1476
Cardiac arrest following use of sumatriptan.
@en
P2093
P304
P356
10.1212/WNL.45.6.1211
P407
P577
1995-06-01T00:00:00Z